DCGO vs. SHCR, PIII, QSI, WGS, PNTG, INNV, TALK, BVS, IVVD, and MNMD
Should you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Sharecare (SHCR), P3 Health Partners (PIII), Quantum-Si (QSI), GeneDx (WGS), The Pennant Group (PNTG), InnovAge (INNV), Talkspace (TALK), Bioventus (BVS), Invivyd (IVVD), and Mind Medicine (MindMed) (MNMD).
DocGo (NASDAQ:DCGO) and Sharecare (NASDAQ:SHCR) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, community ranking, valuation, analyst recommendations and dividends.
DocGo has higher revenue and earnings than Sharecare. Sharecare is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.
In the previous week, Sharecare had 5 more articles in the media than DocGo. MarketBeat recorded 8 mentions for Sharecare and 3 mentions for DocGo. DocGo's average media sentiment score of 0.45 beat Sharecare's score of 0.17 indicating that DocGo is being referred to more favorably in the media.
56.4% of DocGo shares are owned by institutional investors. Comparatively, 35.1% of Sharecare shares are owned by institutional investors. 13.8% of DocGo shares are owned by insiders. Comparatively, 29.3% of Sharecare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
DocGo presently has a consensus target price of $11.83, suggesting a potential upside of 192.90%. Sharecare has a consensus target price of $2.00, suggesting a potential upside of 160.59%. Given DocGo's stronger consensus rating and higher possible upside, analysts plainly believe DocGo is more favorable than Sharecare.
DocGo received 27 more outperform votes than Sharecare when rated by MarketBeat users. Likewise, 68.75% of users gave DocGo an outperform vote while only 40.00% of users gave Sharecare an outperform vote.
DocGo has a net margin of 1.10% compared to Sharecare's net margin of -25.55%. DocGo's return on equity of 2.01% beat Sharecare's return on equity.
DocGo has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Comparatively, Sharecare has a beta of 0.29, indicating that its share price is 71% less volatile than the S&P 500.
Summary
DocGo beats Sharecare on 16 of the 18 factors compared between the two stocks.
Get DocGo News Delivered to You Automatically
Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools